May 12, 2020

Editorial

Coronavirus cases in the US topped 1 million in late April. Although total numbers of cases and deaths change daily and vary greatly among urban vs rural regions of the country, it’s safe to say we haven’t yet seen the last of the surges.

Despite ongoing shortages of personal protective equipment, testing, and—in some facilities—healthcare providers, the government’s mid-April announcement of a phased reopening of businesses gave hospitals and ambulatory surgery centers (ASCs) the green light they needed to reschedule elective procedures that had been on hold.

Leading healthcare organizations acted quickly to issue guidelines for resuming surgery and hosted webinars to recommend best practices (“OR leaders chart new territory for resuming elective surgery,” cover story). In addition, OR Manager spoke with leaders at two different US facilities to share their experience thus far with COVID-19 (“Children’s hospital revises patient care criteria for COVID-19,” cover; “ASCs following new rules for safety during pandemic,” p 9).

Given the ongoing uncertainty about the timeline of the virus, including a possible resurgence later on, we will continue to follow developments.

 

Financial fallout

Although we are still in the midst of the pandemic, researchers have already begun to assess the cost implications associated with it. One recent study projects a median cost of $3,045 in direct medical costs for a single symptomatic COVID-19 infection. Cost estimates for 20% of the total US population getting infected are projected to be $163.4 billion, and that number rises to $645 billion if as much as 80% of the population gets infected.

The study’s authors note that direct medical costs are higher than those of other common infectious diseases like influenza because COVID-19 patients have a higher likelihood of hospitalization and mortality. And these enormous projected expenditures, they say, are conservative estimates that do not account for associated costs such as loss of productivity, premature mortality, worse disease outcomes resulting from postponed preventive care and diagnosis, or some of the price gouging that has occurred as a result of supply scarcity.

In addition to the high number of deaths and ongoing danger of exposure to the virus, the financial impact of delaying surgical procedures cannot be overstated. A “National Hospital Flash Report” issued by consulting firm Kaufman Hall in April shows staggering losses sustained in March:

• Median operating margins dropped from 4% in February to -8% in March for hospitals nationwide.

• Operating earnings before interest, taxes, depreciation, and amortization (EBITDA) fell 100% compared to March 2019, or 13 percentage points in absolute change.

• The temporary cancellation of elective and non-emergent procedures resulted in a 19% drop in operating minutes for the same period year over year.

Each day brings more reports of layoffs, furloughs, reduced hours, and pay cuts at businesses nationwide. A total of 42,500 healthcare industry jobs were lost in March, mostly in the ambulatory care sector.

 

Other challenges

As healthcare organizations begin to resume surgical procedures and strive to meet the new safety standards imposed by COVID-19, they also face several other challenges. Millions of people have lost their jobs, and many have also lost employer-based insurance. “A lot of these patients are going to have to be financially cleared again,” Jonathan Wiik, principal of healthcare strategy at TransUnion Healthcare, told HealthLeaders Media. He recommends assessing patients’ ability to pay and also their current health status—because if they are now sicker than before, the procedure could be costlier.

Noting the complexity of rescheduling cases, Wiik also suggests cross-training billers or registrars in clinics to help, and to make sure that all of the necessary staff and equipment are available.

Perhaps the biggest challenge of all is convincing patients that the surgical environment is now safe. According to a TransUnion survey conducted in mid-April, nearly 50% of patients who had an elective procedure deferred said they would only reschedule once they no longer believe there is a high risk of COVID-19 infection or once guidelines advise it is safe. To reassure patients, Wiik advises giving schedulers some talking points related to the facility’s decision-making processes and infection control protocols.

 

Here to help

OR Manager devoted the entire May issue to COVID-19, and daily developments are being reported in OR a.m. The toll taken by the disease goes far beyond financial consequences. We will continue to bring you the resources and information you need to ensure safe patient care in the current environment.

OR Manager offers an opportunity for perioperative services leaders across the nation to learn from one another. How is your organization managing during the pandemic? If you would like to share your experience and help your colleagues, please contact me at ewood@accessintel.com. And meanwhile, please stay safe. ✥

 

References

Barrow T. Outpatient care gets walloped by COVID-19 in March job losses. Modern Healthcare. April 3, 2020. https://www.modernhealthcare.com/providers/outpatient-care-gets-walloped-covid-19-march-job-losses.

 

Bartsch S M, Ferguson M C, McKinnell J A, et al. The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff (Millwood). Published ahead of print April 23, 2020.

 

Kaufman Hall. National Hospital Flash Report. April 2020. https://www.modernhealthcare.com/providers/outpatient-care-gets-walloped-covid-19-march-job-losses.

 

Pecci A W. 3 revenue cycle hurdles for resuming elective procedures. HealthLeaders Media. April 28, 2020. https://www.healthleadersmedia.com/finance/3-revenue-cycle-hurdles-resuming-elective-procedures.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat